Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal

Document 2025-21407 is a Proposed Rule published by the Food and Drug Administration in the Federal Register on November 28, 2025. The Food and Drug Administration (FDA, Agency, or we) is announcing the withdrawal of the proposed rule entitled "Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products," which published in the Federal Register of December 27, 2024. FDA is taking this action in response to comments received during the comment period for the proposed rule that warrant further consideration and assessment prior to issuing final regulations to establish and require standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products pursuant to the Modernization of Cosmetics Regulation Act of 2022. View the original at https://www.federalregister.gov/documents/2025/11/28/2025-21407/testing-methods-for-detecting-and-identifying-asbestos-in-talc-containing-cosmetic-products.

No. Document 2025-21407 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.